A detailed history of Two Sigma Securities, LLC transactions in Allakos Inc. stock. As of the latest transaction made, Two Sigma Securities, LLC holds 11,787 shares of ALLK stock, worth $3,418. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,787
Holding current value
$3,418
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$0.62 - $1.5 $7,307 - $17,680
11,787 New
11,787 $14,000
Q3 2023

Nov 14, 2023

BUY
$2.13 - $5.55 $22,690 - $59,124
10,653 New
10,653 $24,000

Others Institutions Holding ALLK

About Allakos Inc.


  • Ticker ALLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,726,096
  • Market Cap $24.6M
  • Description
  • Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...
More about ALLK
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.